Fatty Liver: all 1,462 studies
Page 8 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to HepatologyCompletedNCT05370053Not applicable
- Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLDStatus unknownNCT05359471Not applicable
- Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)Status unknownNCT05358496
- Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASHCompletedNCT05357248Not applicable
- Metabolic Effects of Plant-based DietCompletedNCT05351853Not applicable
- Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient ElastographyCompletedNCT05351515
- Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASHCompletedNCT05343780Phase 2
- Effect of Molecular Hydrogen in Patients With NAFLDCompletedNCT05325398Not applicable
- A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)CompletedNCT05320146
- Steatohepatitis in Chronic Hepatitis BCompletedNCT05317260
- Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) StudyCompletedNCT05309642Not applicable
- A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05308160Phase 3
- Attenuation Imaging in Hepatic SteatosisStatus unknownNCT05302258
- Omics-based Predictors of NAFLD/Potential NASHStatus unknownNCT05301231
- A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy SubjectsCompletedNCT05294458Phase 1
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)CompletedNCT05292911Phase 1
- Pentoxifylline in Treatment of Patients With Nonalcoholic SteatohepatitisCompletedNCT05284448Phase 3
- Efficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic SteatosisCompletedNCT05280145Not applicable
- Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic SteatosisCompletedNCT05265026Not applicable
- Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)CompletedNCT05259475Not applicable
- Ursodeoxycholic Acid in Patients With NAFLD - Clinical ObservationActive, not recruitingNCT05256979
- Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic SteatohepatitisCompletedNCT05254626Phase 2
- Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD IndividualsStatus unknownNCT05245890
- Hybrid Training and Middle AgeCompletedNCT05231564Not applicable
- Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouchCompletedNCT05224037Not applicable
- Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.Status unknownNCT05218538
- Healthy Liver - Healthy BrainCompletedNCT05216796Not applicable
- Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05209100
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy SubjectsWithdrawnNCT05203367Phase 1
- "LiverColor": Machine Learning in Liver PhotographsStatus unknownNCT05202886Not applicable
- Impact Of Choline in Patients With NAFLDStatus unknownNCT05200156Not applicable
- Identification and Characterization of NAFLD in TurkeyCompletedNCT05194553
- Electrical Impedance Tomography in Fatty Liver DetectionCompletedNCT05189990
- Novel MRE Technique to Assess a Risk Factor for Liver CancerActive, not recruitingNCT05165446
- Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver DiseaseWithdrawnNCT05130346Not applicable
- Characterization of the Platelet Inflammatory Response in NAFL and NASHStatus unknownNCT05128253
- Lifestyle Modification in Psoriatic Patients With Fatty LiverStatus unknownNCT05125757Not applicable
- TREating Pediatric ObesityCompletedNCT05124847Not applicable
- Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHStatus unknownNCT05120557Not applicable
- Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASHWithdrawnNCT05118360Phase 2
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)CompletedNCT05117489Phase 1
- Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis TestStatus unknownNCT05108415
- Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.Status unknownNCT05106049
- A Study of ALG-055009 in Healthy Volunteers and Subjects With HyperlipidemiaCompletedNCT05090111Phase 1
- Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05084404Phase 2
- Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2CompletedNCT05081427
- Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty LiverStatus unknownNCT05076058Not applicable
- A Clinical Trial of XZP-6019 Tablets in Healthy SubjectsStatus unknownNCT05063968Phase 1
- Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes MellitusStatus unknownNCT05054712
- A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy ParticipantsCompletedNCT05053165Phase 1
- Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced FibrosisWithdrawnNCT05050721
- Anti-diabetic Drugs and Fatty Liver ManagementStatus unknownNCT05041673Not applicable
- A Study of JNJ-75220795 in Japanese ParticipantsTerminatedNCT05039710Phase 1
- Effects of Plant Sterols and Stanols on Liver InflammationStatus unknownNCT05037890Not applicable
- PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation CirrhosisCompletedNCT05022693Phase 1
- Effects of Online App Weight Loss Programs on Liver Health in Obese AdultsCompletedNCT05015491Not applicable
- FTIH Study of ECC0509 in Healthy VolunteersCompletedNCT05012423Phase 1
- ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT05006885Phase 1
- Predicting Obesity Consequences Using Body Measure and Urine MetabolomicsStatus unknownNCT04989062
- "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.CompletedNCT04988633Not applicable
- Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up StudyCompletedNCT04988230Not applicable
- Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver DiseaseCompletedNCT04988204Not applicable
- Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter StudyStatus unknownNCT04985188
- COVID-19 and Nonalcoholic Fatty Liver DiseaseCompletedNCT04982328
- Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) PatientsCompletedNCT04977661Phase 4
- Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty LiverStatus unknownNCT04976283Phase 4
- Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus CuppingStatus unknownNCT04971434Not applicable
- Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver DiseaseStatus unknownNCT04946786
- Effect of F. Prausnitzii on Glycemic ControlStatus unknownNCT04938843Not applicable
- A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224CompletedNCT04932512Phase 2
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy VolunteersCompletedNCT04931147Phase 1
- A Phase I Clinical Trial of XZP-5610 Tablets in Healthy SubjectsStatus unknownNCT04913090Phase 1
- Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic SteatosisCompletedNCT04907721Not applicable
- Dietary Fructose on Microbiota and HepatosteatosisCompletedNCT04898621Not applicable
- Bariatric Endoscopy and NAFLDActive, not recruitingNCT04895943
- Study on GS300 on NAFLDStatus unknownNCT04887766Not applicable
- First-in-Human Study of SRT-015 in Healthy Subjects.CompletedNCT04887038Phase 1
- Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT04882644Not applicable
- Safety, Tolerability, and Efficacy of AXA1125 in NASH With FibrosisStatus unknownNCT04880187Phase 2
- Mobile Health Delivered Lifestyle Intervention Program in Patients With NASHCompletedNCT04872777Not applicable
- Lifestyle Modification for MAFLD Based on TTMStatus unknownNCT04871880Not applicable
- Effect of L-Citrulline Supplementation on NAFLD in Adolescents With ObesityCompletedNCT04871360Not applicable
- Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, EgyptStatus unknownNCT04861012Not applicable
- The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid TurnoverCompletedNCT04859322Not applicable
- Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver DiseaseCompletedNCT04857606Phase 1
- Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM ConstitutionCompletedNCT04853082Early Phase 1
- Effect of Fatty Liver Disease on Bone DensityStatus unknownNCT04850547
- Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver DiseaseCompletedNCT04845373Not applicable
- A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795CompletedNCT04844450Phase 1
- Dairy Protien Rich Diet for NAFLD PatientsCompletedNCT04841915Not applicable
- Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease PatientsCompletedNCT04834063
- The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy SubjectsCompletedNCT04829123Phase 1
- Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL ManagementCompletedNCT04823676Not applicable
- Gut Microbiota in Chronic Noncommunicable DiseasesCompletedNCT04820556
- A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.CompletedNCT04808154Phase 1
- Low-Calorie Diet in People With Prediabetes/Metabolic SyndromeCompletedNCT04786418Not applicable
- Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenStatus unknownNCT04783116Not applicable
- Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationCompletedNCT04782050Not applicable
- Chronic Kidney Disease and Non-alcoholic Fatty Liver DiseasesCompletedNCT04779905
- Study to Evaluate MET642 in Patients With NASHCompletedNCT04773964Phase 2